The FDA will open a 13-member branch office in the US embassy in Beijing, the first foreign-located branch for the agency. The new office will attempt to prevent China-related safety problems before they happen. The safety problems are critical because China is the number one supplier of APIs to the US. More details...

Also click here to read the related "In My Opinion" free article.